Seoul: Osstem Implant, South Korea-based dental implant manufacturer, is strengthening its presence in India as the country’s dental implant market undergoes rapid transformation.
Rising middle-class incomes, longer life expectancy, and growing patient preference for quality and advanced technology are driving this demand shift.
Global expansion with India as a key market
Traditionally dominated by European manufacturers, the dental implant sector is now being reshaped by Korean companies.
Also Read: Trust AI Raises USD 6 Million to Build Operating System for Future of Dentistry
Osstem Implant ranks third globally in market share, exporting to over 100 countries and managing 37 subsidiaries across 32 nations. Among these, India is one of the fastest-growing markets and a critical part of Osstem Implant’s global expansion strategy.
Innovation and education fueling Osstem Implant’s growth
Osstem Implant’s success in India is driven by a combination of technological innovation and professional education. The company offers five implant designs and four surface technologies tailored to diverse clinical needs. Its implants ensure high initial stability, faster treatment timelines, and long-term reliability.
In parallel, Osstem invests heavily in professional training. Through its flagship “Master Course,” held more than 100 times across India in the last year, over 1,300 dentists were trained in advanced implantology, building a confident network of practitioners well-versed in Osstem Implant systems.
Also Read: Laxmi Dental Q1 FY26: Revenue Rises 10 Per Cent to INR 656 Million; PAT at INR 83 Million
Clinical validation and product excellence
The company’s technological advancements are backed by scientific research. A study published in the international journal Materials highlighted the effectiveness of Osstem Implant’s SA surface treatment in enhancing osseointegration and bone density.
Its best-selling TS III product has consistently achieved strong clinical success rates, with Indian dentists reporting quicker recovery and higher patient satisfaction compared with alternatives.
Financial performance and global recognition
In 2024, Osstem Implant recorded consolidated revenues of USD 930 million (KRW 1.3 trillion), with nearly 70% of sales generated from overseas markets. India, along with China and Russia, contributed significantly to this growth. Analysts attribute Osstem’s success to continuous R&D, product innovation, and sustained investment in dentist education.
